So my understanding of the 8-K is that $EHSK will be given shares of Integumen based at 1lb per share or $1.30 per share to buy the assets. So essentially $EHSK will own over 3 million shares of Integumen. Per section 5.14 in the 8-K, it appears $EHSK can distribute Integumen's shares to its shareholders. Since $EHSK has 115mil shares outstanding, the 3mil shares of Integumen would equate to 38.4 shares of EHSK = 1 Integumen share at par value of $1.3 US per share. So dividing $1.3 by 38.4 = $.034 CURRENT share value of EHSK. And now we have ZERO debt and own 24% of Integumen (Innovenn). And who thinks Integumen share value is going to go down? Long-term hold here with serious potential for major appreciation...
"One of the funny things about the stock market is that every time one person buys, another sells, and both think they are astute." - William Feather.
